1. Home
  2. YMAT vs RGNT Comparison

YMAT vs RGNT Comparison

Compare YMAT & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$1.49

Market Cap

9.9M

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.85

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YMAT
RGNT
Founded
1970
2004
Country
Taiwan
Israel
Employees
65
8
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
11.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YMAT
RGNT
Price
$1.49
$1.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.0M
24.6K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$1.82
52 Week High
$6.45
$8.35

Technical Indicators

Market Signals
Indicator
YMAT
RGNT
Relative Strength Index (RSI) 60.64 32.38
Support Level $0.41 $1.82
Resistance Level $2.26 $3.35
Average True Range (ATR) 0.54 0.22
MACD 0.03 0.01
Stochastic Oscillator 42.89 11.04

Price Performance

Historical Comparison
YMAT
RGNT

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: